The Journal of Pharma and Drug Innovation (JPDI) is dedicated to advancing high-quality scholarly research in pharmaceutical sciences and drug development. The journal publishes original research articles, review articles, short communications, and case studies related to drug discovery, formulation science, pharmacological evaluation, and therapeutic research.

JPDI focuses on emerging developments in drug delivery systems, pharmaceutical chemistry, pharmacokinetics, regulatory science, and pharmaceutical biotechnology, with the aim of facilitating the translation of research findings into clinical practice and pharmaceutical applications.

The journal welcomes interdisciplinary contributions that integrate pharmacy, medicine, chemistry, biotechnology, and life sciences to address current challenges in pharmaceutical research and clinical therapeutics.

Areas of interest include:

• Drug design, discovery, and development
• Advanced and targeted drug delivery systems
• Pharmacology and pharmacodynamics
• Pharmaceutical formulation and quality assurance
• Clinical pharmacology and therapeutic innovation
• Natural product drug development and toxicological studies
• Nanomedicine and biosimilar development
• Regulatory science, GMP compliance, and pharmacovigilance
• Rational drug use, healthcare policy, and patient safety

Through the dissemination of high-quality, evidence-based research, JPDI aims to advance pharmaceutical sciences, therapeutic innovation, and public health. The journal encourages collaboration among researchers, academics, healthcare professionals, and industry experts worldwide.